Glibenclamide in patients with poorly controlled type 2 diabetes: a 12-week, prospective, single-center, open-label, dose-escalation study

Rambiritch V, Maharaj B, Naidoo P
Source: International Journal of COPD - Category: Respiratory Medicine Source Type: research